Harry Glorikian
Harry Glorikian is a General Partner at Scientia Ventures and a Research Affiliate at the MIT Media Lab. With more than three decades of experience building and investing in companies at the intersection of healthcare, life sciences, and emerging technology, Harry is one of the leading voices on AI strategy, the economics of the AI layer, and what the intelligent interface era means for boards, investors, and executives.
Harry is well known for his achievements in life sciences, healthcare, diagnostics, healthcare IT, and the convergence of these areas. He is a sought-after speaker, frequently quoted in the media, and regularly asked to assess, influence, and be part of innovative concepts and trends.
He holds 4 US patents in telecommunications and has others pending.
The new healthcare business paradigm is measure → optimize → transform.
He currently serves as a General Partner at Scientia Ventures and is a Research Affiliate at the MIT Media Lab. Before joining Scientia Ventures, he served as an Entrepreneur-In-Residence to GE Ventures – New Business Creation Group, leading to the founding of Evidation Health and DrawBridge Health.
Previously he co-founded and held the position of managing director and head of consulting services for Scientia Advisors, a company that became the go-to provider of strategic advice and implementation services for next-generation healthcare and life science innovators and Global 25 market leaders.
Scientia Advisors was acquired by Precision for Medicine in November of 2012.
Among his other professional roles, Mr. Glorikian served as a senior manager for global business development at PE Applied Biosystems, founded X-Cell Laboratories, managed global sales at Signet Laboratories, and held various roles at BioGenex Laboratories.
If the difference between evolution and revolution is the speed of change, then healthcare is now in the mode of revolutionary change.
Mr. Glorikian holds an MBA from Boston University and a bachelor’s degree from San Francisco State University.
Harry has addressed the National Institutes of Health, Molecular Medicine Tri-Conference, World Theranostics Congress, and other audiences, worldwide. He has authored numerous articles for industry publications, appeared on CBS Evening News and been quoted regularly by Dow Jones, The Boston Globe, BioWorld Today, Los Angeles Times, London Independent, Medical Device Daily, Science Magazine, Genetic Engineering News and many other media outlets.
He is the author of four books:
- The Invisible Interface: How AI Turns Intentions Into Actions–And Who Wins (Ideapress Publishing, distributed by Simon & Schuster — Available June 2026)
- The Future You: How Artificial Intelligence Can Help You Get Healthier, Stress Less, and Live Longer,
- Commercializing Novel IVD’s; A Comprehensive Manual for Success,
- MoneyBall Medicine: Thriving in the New Data-Driven Healthcare Market
Harry is the host of The Harry Glorikian Show podcast series, which covers all about AI, life sciences, tech, and data in healthcare.
Harry is available for keynote presentations, board briefings, and executive workshops on AI strategy, trust architecture, and the economics of the POL era. Contact Harry to inquire about speaking and advisory engagements.